MA H1167

Bill

Relative to prescription drug price transparency

Introduced
01/22/2019

In Committee
01/22/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

By Mr. Jones of North Reading, a petition of Bradley H. Jones, Jr. and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs. Health Care Financing.

AI Summary

This bill aims to enhance prescription drug price transparency in Massachusetts. It requires the Health Policy Commission, in consultation with the Center, to create an annual list of 10 drugs with significant cost increases for the state's MassHealth program. It also requires health insurance carriers with over 5,000 covered lives to create a similar list of 10 drugs with significant cost increases for their plans. The Attorney General's office will then identify up to 15 drugs from these lists and require the manufacturers to provide information and documentation to justify the cost increases. The Attorney General will then report this information to the legislature annually.

Committee Categories

Health and Social Services

Sponsors (14)

Angelo D'Emilia (R), Kim Ferguson (R), Paul Frost (R), Susan Gifford (R), Bradford Hill (R), Steven Howitt (R), Randy Hunt (R), Brad Jones (R), Hannah Kane (R), Shaunna O'Connell (R), Norm Orrall (R), Elizabeth Poirier (R), Todd Smola (R), Donald Wong (R),

Last Action

Reporting date extended to Thursday December 31, 2020, pending concurrence (on 06/22/2020)

Official Document

https://malegislature.gov/Bills/191/H1167

(8 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/191/H1167
Bill	https://malegislature.gov/Bills/191/H1167.pdf

Bill	Bill Name	Last Action	Type
S1149	Strengthening prescription drug safety and drug stewardship	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S1277	Relative to the prescription monitoring program	Accompanied a study order, see S2683	Similar To
S2397	Relative to pharmaceutical access, costs and transparency	Reprinted as amended, see S2409	Similar To
S2409	Relative to pharmaceutical access, costs and transparency	Read; and referred to the committee on House Ways and Means	Similar To
S552	To promote transparency in prescription drug prices	Accompanied a study order, see S2543	Similar To
S570	Relative to out-of-pocket expenses for prescription drug coverage	Accompanied a study order, see S2543	Similar To
S582	Ensuring access to medications	Accompanied a study order, see S2543	Similar To
S721	Relative to mandatory prescription drug coverage	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To

Bill > H1167

MA H1167

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (14)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary